| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb258be6a48fd6826b8c923ea4234dff |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2014-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d79e1fbc13d2be7ac75aebe0db60cc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1037965dab3ba337b2a52a243089349
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99514564c38d8a312e6a995f896bae1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_877c6be835efdce8d12ae61bcbf87fe7 |
| publicationDate |
2016-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016220711-A1 |
| titleOfInvention |
Methods and compositions for tumor vasculature imaging and targeted therapy |
| abstract |
Provided are compositions and methods for imaging one or more of tumor vasculature and tumor angiogenesis, wherein an imaging composition comprises anti-SFRP2 antibody operable linked to an imaging agent. Provided is a method of imaging tumor vasculature in an individual comprising administering to the individual a diagnostically effect of an imaging composition, and detecting the image resulting from the binding or complexing of the imaging composition with tumor vasculature. The imaging agent may also be used as a delivery vehicle to target one or more therapeutic agents to tumor vasculature and surrounding tumor tissue. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441215-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10249037-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9966365-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10575774-B2 |
| priorityDate |
2013-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |